Constance Schultsz

Constance Schultsz

  • Director of Science
  • Senior Fellow
  • Professor of Global Health, Department of Global Health, Amsterdam UMC, University of Amsterdam
  • Deputy Head, Department of Global Health, Academic Medical Center, University of Amsterdam

Professor Constance Schultsz is an MD, Medical Microbiologist and Professor of Global Health, in particular for emerging infectious diseases and antibiotic resistance, at the Amsterdam UMC of the University of Amsterdam (UvA) Her research interests include zoonotic and emerging infectious diseases, in particular Streptococcus suis, and antibiotic resistance. She is interested in molecular epidemiology and pathogenesis, next-generation sequencing applications, smart sampling strategies for antimicrobial resistance surveillance, as well as behavioural and socio-economic drivers of antimicrobial resistance. Constance Schultsz is the coordinator of the EU JPI-AMR consortium HECTOR and Chair of the Public Private Partnership AMR-Global.

Constance Schultsz has previously worked as a Research Fellow at the International Centre for Diarrheal Diseases Research, Bangladesh (ICDDR) in Dhaka, Bangladesh and worked as a consultant microbiologist at the VU University Medical Centre. From 2003 until 2008 she headed the Microbiology department at the Oxford University Clinical Research Unit, Vietnam, at the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam. In 2008 she joined the Amsterdam UMC in the departments of Global Health and Medical Microbiology. She was appointed Deputy Head of the Department of Global Health in 2016 and at the same time became an executive board member of the AIGHD.

View Constance’s publications (PubMed). 


Filling the gaps in the global prevalence map of clinical antimicrobial resistance. Oldenkamp R, Schultsz C, Mancini E, Cappuccio A.Proc Natl Acad Sci U S A. 2021 Jan 5;118(1):e2013515118. doi: 10.1073/pnas.2013515118.PMID: 33372157

Metagenomic DNA sequencing for semi-quantitative pathogen detection from urine: a prospective, laboratory-based, proof-of-concept study. Janes VA, Matamoros S, Munk P, Clausen PTLC, Koekkoek SM, Koster LAM, Jakobs ME, de Wever B, Visser CE, Aarestrup FM, Lund O, de Jong MD, Bossuyt PMM, Mende DR, Schultsz C.Lancet Microbe. 2022 Jun 7:S2666-5247(22)00088-X. doi: 10.1016/S2666-5247(22)00088-X. Online ahead of print.PMID: 35688170

Antimicrobial resistance in uropathogens and appropriateness of empirical treatment: a population-based surveillance study in Indonesia.
Sugianli AK, Ginting F, Kusumawati RL, Pranggono EH, Pasaribu AP, Gronthoud F, Geerlings S, Parwati I, De Jong MD, Van Leth F, Schultsz C.
J Antimicrob Chemother. 2017 May 1;72(5):1469-1477. doi: 10.1093/jac/dkw578.
PMID: 28137940

Effects of infection control measures on acquisition of five antimicrobial drug-resistant microorganisms in a tetanus intensive care unit in Vietnam.
Schultsz C, Bootsma MC, Loan HT, Nga TT, Thao le TP, Thuy TT, Campbell J, Vien le M, Hoa NT, Hoang NV, Wit F, Chau NV, Farrar J, Bonten MJ, Yen LM.
Intensive Care Med. 2013 Apr;39(4):661-71. doi: 10.1007/s00134-012-2771-1. Epub 2013 Jan 10.
PMID: 23306583

Network building and knowledge exchange with telemicrobiology.
Schultsz C, Lan NP, Van Dung N, Visser C, Anh TT, Bay PV, Hong TT, Brinke P, Hendriks W, Osinga T, van der Waals F, Botma J, Hien TT, Farrar JJ, van Doorn HR, Chau NV, de Jong MD.
Lancet Glob Health. 2014 Feb;2(2):e78. doi: 10.1016/S2214-109X(13)70112-8. Epub 2014 Jan 23. No abstract available. Erratum in: Lancet Glob Health. 2014 Apr;2(4):e208.
PMID: 25104663